Wave Life Sciences (WVE) Reports Q3 Loss, Misses Revenue Estimates
Wave Life Sciences (WVE) delivered earnings and revenue surprises of -6.67% and -41.25%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?